In other tumor types, BAP1 mutations have been associated with both increased and decreased survival: while BAP1 expression loss and germline mutations are associated with survival benefit in malignant pleural mesothelioma [26,27], they are linked to worse survival in uveal melanoma and clear cell renal cell carcinoma [28]. This evidence concerns the gene BAP1 and malignant pleural mesothelioma.